Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
25
Number of overlapping holdings
64.1%
% of GNOM's 40 holdings also in WDNA
29.8%
% of WDNA's 90 holdings also in GNOM
Overlap by Weight
Sector Drift (GNOM minus WDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in GNOM |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 6.3% | 3.7% | 3.7% |
|
VERACYTE INC | 4.8% | 2.1% | 2.1% |
|
GILEAD SCIENCES INC | 3.3% | 1.9% | 1.9% |
|
VERTEX PHARMACEUTICALS INC | 2.7% | 1.8% | 1.8% |
|
ALNYLAM PHARMACEUTICALS INC | 4.7% | 1.6% | 1.6% |
Position Highlights (Non-Overlapping Exposures)
GNOM Overweight Relative to WDNA
|
AGILENT TECHNOLOGIES INC | 4.5% |
|
BIOMARIN PHARMACEUTICAL INC | 4.3% |
 |
GENSCRIPT BIOTECH CORPORATION | 4.2% |
|
LEGEND BIOTECH CORPORATION SPONSORED | 4.1% |
|
AVIDITY BIOSCIENCES INC | 3.6% |
|
BIO-TECHNE CORPORATION | 3.3% |
 |
BIONTECH SE SPONSORED ADR | 3.2% |
|
ALNYLAM PHARMACEUTICALS INC | 3.1% |
|
CRISPR THERAPEUTICS AG | 2.9% |
|
ARROWHEAD PHARMACEUTICALS, INC. | 2.8% |
GNOM Underweight Relative to WDNA
|
TWIST BIOSCIENCE CORP. | -3.3% |
 |
NOVOZYMES A/S-B SHARES | -2.9% |
|
ELI LILLY & CO | -2.7% |
|
VERICEL CORPORATION | -2.6% |
|
BLUEPRINT MEDICINES CORP. | -2.6% |
|
BRIDGEBIO PHARMA, INC. | -2.4% |
|
AGIOS PHARMACEUTICALS INC | -1.9% |
|
UNITED THERAPEUTICS CORP | -1.7% |
|
AMGEN INC | -1.7% |
 |
NOVARTIS AG | -1.7% |